Oral reactive capillary hemangiomas induced by SHR-1210 in the treatment of non-small cell lung cancer: a case report and literature review

BACKGROUND: Antibodies to PD-1 and PD-L1 have remarkably improved the overall survival of many patients with advanced solid tumors. SHR-1210 is an anti-PD-1 monoclonal antibody. Dermatologic reactive capillary hemangiomas (RCH) were the most common and unique drug-related AEs of SHR-1210, but rare o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jinhan, Mao, Qinghua, Li, Yining, Li, Zhiyong, He, Hong, Chen, Qianming, Liu, Chuanxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561900/
https://www.ncbi.nlm.nih.gov/pubmed/34727912
http://dx.doi.org/10.1186/s12903-021-01901-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561900/
https://www.ncbi.nlm.nih.gov/pubmed/34727912
http://dx.doi.org/10.1186/s12903-021-01901-9

Ejemplares similares